AAAAAA

   
Results: 1-8 |
Results: 8
Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulasfrom the United States Renal Data System Dialysis Morbidity and Mortality Study
Authors: Gibson, KD Gillen, DL Caps, MT Kohler, TR Sherrard, DJ Stehman-Breen, CO
Citation: Kd. Gibson et al., Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulasfrom the United States Renal Data System Dialysis Morbidity and Mortality Study, J VASC SURG, 34(4), 2001, pp. 694-700
Risk factors and mortality associated with calciphylaxis in end-stage renal disease
Authors: Mazhar, AR Johnson, RJ Gillen, D Stivelman, JC Ryan, MJ Davis, CL Stehman-Breen, CO
Citation: Ar. Mazhar et al., Risk factors and mortality associated with calciphylaxis in end-stage renal disease, KIDNEY INT, 60(1), 2001, pp. 324-332
Assessment of a policy to reduce placement of prosthetic hemodialysis access
Authors: Gibson, KD Caps, MT Kohler, TR Hatsukami, TS Gillen, DL Aldassy, M Sherrard, DJ Stehman-Breen, CO
Citation: Kd. Gibson et al., Assessment of a policy to reduce placement of prosthetic hemodialysis access, KIDNEY INT, 59(6), 2001, pp. 2335-2345
Risk factors for hip fracture among patients with end-stage renal disease
Authors: Stehman-Breen, CO Sherrard, DJ Alem, AM Gillen, DL Heckbert, SR Wong, CS Ball, A Weiss, NS
Citation: Co. Stehman-breen et al., Risk factors for hip fracture among patients with end-stage renal disease, KIDNEY INT, 58(5), 2000, pp. 2200-2205
Determinants of type and timing of initial permanent hemodialysis vascularaccess
Authors: Stehman-Breen, CO Sherrard, DJ Gillen, D Caps, M
Citation: Co. Stehman-breen et al., Determinants of type and timing of initial permanent hemodialysis vascularaccess, KIDNEY INT, 57(2), 2000, pp. 639-645
Racial differences in bone mineral density and bone loss among end-stage renal disease patients
Authors: Stehman-Breen, CO Sherrard, D Walker, A Sadler, R Alem, A Lindberg, J
Citation: Co. Stehman-breen et al., Racial differences in bone mineral density and bone loss among end-stage renal disease patients, AM J KIDNEY, 33(5), 1999, pp. 941-946
Prescription of hormone replacement therapy in postmenopausal women with renal failure
Authors: Stehman-Breen, CO Gillen, D Gipson, D
Citation: Co. Stehman-breen et al., Prescription of hormone replacement therapy in postmenopausal women with renal failure, KIDNEY INT, 56(6), 1999, pp. 2243-2247
The cyclin kinase inhibitor p21(WAF1/CIP1) is required for glomerular hypertrophy in experimental diabetic nephropathy
Authors: Al-Douahji, M Brugarolas, J Brown, PAJ Stehman-Breen, CO Alpers, CE Shankland, SJ
Citation: M. Al-douahji et al., The cyclin kinase inhibitor p21(WAF1/CIP1) is required for glomerular hypertrophy in experimental diabetic nephropathy, KIDNEY INT, 56(5), 1999, pp. 1691-1699
Risultati: 1-8 |